Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis

Pediatr Infect Dis J. 2000 Oct;19(10):1015-7. doi: 10.1097/00006454-200010000-00018.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Cefotaxime / pharmacology*
  • Cefotaxime / therapeutic use
  • Ceftriaxone / pharmacology*
  • Ceftriaxone / therapeutic use
  • Cephalosporin Resistance
  • Cephalosporins / pharmacology*
  • Cephalosporins / therapeutic use
  • Cerebrospinal Fluid / microbiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Meningitis, Pneumococcal / drug therapy*
  • Meningitis, Pneumococcal / microbiology*
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • Streptococcus pneumoniae / drug effects*
  • Treatment Outcome

Substances

  • Cephalosporins
  • Ceftriaxone
  • Cefotaxime